NCT00028639View on ClinicalTrials.gov

PS-341 in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2001

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Breast Cancer
Interventions
DRUG

bortezomib

Trial Locations (1)

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00028639 - PS-341 in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter